Mycophenolate mofetil Completed Phase 3 Trials for Nephritis, Lupus / Systemic Lupus Erythematosus (SLE) Treatment

CompletedTreatment3 IdentifierTitleDrugs
NCT01714817Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis
NCT01042457Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis
NCT00282347A Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 Class III or IV Lupus Nephritis
NCT00204022Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis.
NCT00377637A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis.
NCT00626197A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG)